Charles H. Bowden

1.2k total citations · 1 hit paper
8 papers, 878 citations indexed

About

Charles H. Bowden is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Charles H. Bowden has authored 8 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Psychiatry and Mental health. Recurrent topics in Charles H. Bowden's work include Sexual function and dysfunction studies (4 papers), Pharmacology and Obesity Treatment (4 papers) and Urinary Bladder and Prostate Research (3 papers). Charles H. Bowden is often cited by papers focused on Sexual function and dysfunction studies (4 papers), Pharmacology and Obesity Treatment (4 papers) and Urinary Bladder and Prostate Research (3 papers). Charles H. Bowden collaborates with scholars based in United States. Charles H. Bowden's co-authors include Wesley Day, Craig A. Peterson, Michael Schwiers, David B. Allison, Kishore M. Gadde, W. Timothy Garvey, Donna H. Ryan, Michelle Look, Karen DiDonato and David Winslow and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Clinical Nutrition and The Journal of Urology.

In The Last Decade

Charles H. Bowden

8 papers receiving 832 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

2011 501 citations W. Timothy Garvey, Donna H. Ryan et al. American Journal of Clinical Nutrition profile →

Peers

Charles H. Bowden

EDM

PHARM

PHYSI

PMH

SURGE

PETER Y. TAM United States

Adriano Fregonesi Brazil

Silvia Donati Italy

Sae Chul Kim South Korea

Emanuela Amici Italy

H. Porst Germany

Karl Erik Andersson United States

Doris Huebler Germany

Dafna Frydman Israel

R Flamia Italy

PETER Y. TAM United States

Charles H. Bowden

711 ×1.3

EDM

440 ×0.9

PHARM

254 ×0.8

PHYSI

513 ×2.1

PMH

136 ×1.3

SURGE

Citations per year, relative to Charles H. Bowden Charles H. Bowden (= 1×) peers PETER Y. TAM

Countries citing papers authored by Charles H. Bowden

Since Specialization

Citations

This map shows the geographic impact of Charles H. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H. Bowden more than expected).

Fields of papers citing papers by Charles H. Bowden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles H. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H. Bowden. The network helps show where Charles H. Bowden may publish in the future.

Co-authorship network of co-authors of Charles H. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Charles H. Bowden. A scholar is included among the top collaborators of Charles H. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles H. Bowden. Charles H. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Hellstrom, Wayne J.G., Jed Kaminetsky, Laurence Belkoff, et al.. (2015). Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study. The Journal of Urology. 194(2). 485–492. 24 indexed citations

2.

Davidson, Michael H., Serena Tonstad, Suzanne Oparil, et al.. (2013). Changes in Cardiovascular Risk Associated With Phentermine and Topiramate Extended-Release in Participants With Comorbidities and a Body Mass Index ≥27 kg/m2. The American Journal of Cardiology. 111(8). 1131–1138. 25 indexed citations

3.

Goldstein, Irwin, Andrew McCullough, LeRoy Jones, et al.. (2012). A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction. The Journal of Sexual Medicine. 9(4). 1122–1133. 73 indexed citations

4.

Goldstein, Irwin, LeRoy Jones, Laurence Belkoff, et al.. (2012). Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus. Mayo Clinic Proceedings. 87(9). 843–852. 68 indexed citations

5.

Winslow, David, et al.. (2012). A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults. SLEEP. 35(11). 1529–1539. 105 indexed citations

6.

Mulhall, John P., Arthur L. Burnett, Run Wang, et al.. (2012). A Phase 3, Placebo Controlled Study of the Safety and Efficacy of Avanafil for the Treatment of Erectile Dysfunction After Nerve Sparing Radical Prostatectomy. The Journal of Urology. 189(6). 2229–2236. 77 indexed citations

7.

Garvey, W. Timothy, Donna H. Ryan, Michelle Look, et al.. (2011). Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. American Journal of Clinical Nutrition. 95(2). 297–308. 501 indexed citations breakdown →

8.

Davidson, Michael H., Charles H. Bowden, & Wesley Day. (2011). WEIGHT LOSS AND CARDIOVASCULAR RISK REDUCTION OVER 2 YEARS WITH CONTROLLED-RELEASE PHENTERMINE-TOPIRAMATE. Journal of the American College of Cardiology. 57(14). E545–E545. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact